Author

Edward J. Miller

Yale UniversityORCID 0000-0002-2156-5962Unclaimed ORCID profile · follow to get notified of new preprints

Biology Disciplines

Click to filter author papers

Signature Assays, Organisms & Methods

Click to filter · or open tag

Assay:bulk RNA-seq· 2 Research Focus:differential expression· 2 Organism:human· 2 Approach:statistical model· 2 Research Focus:gene regulatory network inference· 1

Frequent Co-Authors

Daniel Louis JacobyiD· 2 shared Dóra KolleriD· 2 shared Frank R. WendtiD· 2 shared Gita A. PathakiD· 2 shared Renato A PolimantiiD· 2 shared Antonella De LilloiD· 1 shared Brenda Cabrera‐MendozaiD· 1 shared Flavio De AngelisiD· 1 shared

Activity by Year

2021-2021 · peak 2/yr

Co-Author Collaboration Network

9 top collaborators · 36 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

2 shared papersGenetic & Genomic Medicine

Daniel Louis JacobyORCID

Mutual co-authors in cluster

Author profile →

2 papers

Recent·Most cited

The integration of genetically-regulated transcriptomics and electronic health records highlights a pattern of medical outcomes related to increased hepatic Transthyretin expression

Gita A. Pathak, Antonella De Lillo, Frank R. Wendt, Flavio De Angelis, Dóra Koller, Brenda Cabrera‐Mendoza, Daniel Louis Jacoby, Edward J. Miller, Joel N. Buxbaum, Renato A Polimanti

This paper integrates genetic transcriptomics and electronic health records to show increased hepatic Transthyretin expression is linked to specific surgical procedures and health outcomes like osteoarthritis and carpal tunnel syndrome.

Amyloid · Dec 22, 2021Peer-reviewedGenetic & Genomic Medicine

Biobank scale pharmacogenomics informs the genetic underpinnings of simvastatin use

Frank R. Wendt, Dóra Koller, Gita A. Pathak, Daniel Louis Jacoby, Edward J. Miller, Renato A Polimanti

This paper identifies associations between NAT2 haplotype variation and simvastatin use, showing NAT2*1 is linked to better response to simvastatin therapy.

Clinical Pharmacology & Therapeutics · Apr 10, 2021Peer-reviewedGenetic & Genomic Medicine